Financials
Financial year 2025
PHARMA JACK from Charleroi, company number BE0875221694, closed financial year 2025 with a result of € 50,320 after tax. For that financial year PHARMA JACK recorded a gross margin of € 375,987 and equity of € 55,519. Compared with financial year 2024, the result moved from € 5,099 to € 50,320. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.
€ 55,519
▼ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 50,320
▲ € 45,221 vs 2024
Profit after tax over the fiscal year.
€ 98,744
▼ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 70,168 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
4.5
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 249,068
▲ 5% vs 2024
€ 55,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 38,197
▼ 21% vs 2024
Of which on lease € 27,395.
Debts at end 2025
€ 270,912
▼ 12% vs 2024
€ 34,702 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 119,403
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 70,980
▲ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 270,987 | € 294,304 | € 299,793 | € 375,987 | ▲ 25% |
| Profit after taxes | € 4,448 | € 10,155 | € 5,099 | € 50,320 | ▲ € 45,221 |
| Equity | € 80,059 | € 90,214 | € 81,567 | € 55,519 | ▼ 32% |
| Total debts | € 478,062 | € 461,908 | € 525,367 | € 548,815 | ▲ 4% |
| Cash | € 70,207 | € 79,765 | € 107,563 | € 98,744 | ▼ 8% |
| Land & buildings | € 217,078 | € 189,964 | € 162,849 | € 135,725 | ▼ 17% |
| Retained profit | € 73,759 | € 83,914 | € 75,267 | € 55,419 | ▼ 26% |
| Dividend | € 0 | € 0 | € 13,746 | € 70,168 | ▲ € 56,422 |
| Bank debt | € 352,989 | € 311,379 | € 309,339 | € 270,912 | ▼ 12% |
| Balance sheet total | € 558,121 | € 552,122 | € 606,935 | € 604,334 | |
| Employees (FTE) | 4.7 | 4.5 | 4.3 | 4.5 | ▲ 0.2 |
Key figures of PHARMA JACK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA JACK?
What happened at PHARMA JACK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 50,320 (▲ € 45,221 vs 2024). filed late Source: NBB ↗
- Florence JACQUET became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
- ANNE-SOPHIE SANDERMANS became a director. NBB
In short
From € 4,448 profit in 2022 to € 50,320 profit in 2025.
Paid € 40,181 in corporate taxes since 2022.
Best year ever: 2025, with € 50,320 profit.
On average € 83,600 of value added per employee in 2025.
A new publication or filing at PHARMA JACK? We notify you, reason included.
Follow PHARMA JACKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA JACK are ANNE-SOPHIE SANDERMANS and Florence JACQUET. Florence JACQUET is also behind ESPACE GLOBAL SANTE and PACT TEXTILE.
Directors
According to the 2025 annual accounts
ANNE-SOPHIE SANDERMANS
Director
since 2005
since 2015
Establishments
Establishment units
Physical locations of this company
Rue des Preys 84
6061 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0875.221.694
- VAT number
- BE 0875.221.694
- Registered office
- Rue des Preys 84, 6061 Charleroi
- Names & denominations
- PHARMA JACK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 July 2005
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Schoonheidsverzorging en andere schoonheidsbehandelingen
Activiteiten op het gebied van voeding
Detailhandel in cosmetica en toiletartikelen
Activiteiten van kuuroorden, sauna’s en stoombaden
Beroepsopleiding
Sauna's, solaria, baden enz.
+2